[{"address1": "1500 District Avenue", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "617 600 7373", "website": "https://www.minervaneurosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Remy  Luthringer Ph.D.", "age": 62, "title": "Executive Chairman & CEO", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1274649, "exercisedValue": 0, "unexercisedValue": 34200}, {"maxAge": 1, "name": "Mr. Geoffrey Robin Race F.C.M.A., M.B.A.", "age": 62, "title": "President", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 913302, "exercisedValue": 0, "unexercisedValue": 28880}, {"maxAge": 1, "name": "Mr. Frederick W. Ahlholm CPA", "age": 57, "title": "Senior VP, CFO & Secretary", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 726017, "exercisedValue": 0, "unexercisedValue": 19760}, {"maxAge": 1, "name": "Mr. Joseph  Reilly", "age": 48, "title": "Senior VP & COO", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 460999, "exercisedValue": 0, "unexercisedValue": 632717}, {"maxAge": 1, "name": "Mr. William B. Boni", "age": 71, "title": "Vice President of Investor Relations & Corporate Communications", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Michael  Davidson M.D.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 657466, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.16, "open": 2.2, "dayLow": 2.08, "dayHigh": 2.21, "regularMarketPreviousClose": 2.16, "regularMarketOpen": 2.2, "regularMarketDayLow": 2.08, "regularMarketDayHigh": 2.21, "beta": 0.17, "forwardPE": -0.82462686, "volume": 47533, "regularMarketVolume": 47533, "averageVolume": 17046, "averageVolume10days": 15370, "averageDailyVolume10Day": 15370, "bid": 1.58, "ask": 2.68, "bidSize": 200, "askSize": 200, "marketCap": 15455436, "fiftyTwoWeekLow": 2.06, "fiftyTwoWeekHigh": 13.49, "fiftyDayAverage": 2.376, "twoHundredDayAverage": 2.68394, "currency": "USD", "enterpriseValue": 48926636, "floatShares": 5437023, "sharesOutstanding": 6993410, "sharesShort": 9544, "sharesShortPriorMonth": 7080, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.22257, "heldPercentInstitutions": 0.30473, "shortRatio": 0.41, "shortPercentOfFloat": 0.0023, "impliedSharesOutstanding": 7142840, "bookValue": -3.099, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -3311546, "trailingEps": -0.45, "forwardEps": -2.68, "lastSplitFactor": "1:8", "lastSplitDate": 1655769600, "enterpriseToEbitda": -1.998, "52WeekChange": -0.6406504, "SandP52WeekChange": 0.2764505, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NERV", "underlyingSymbol": "NERV", "shortName": "Minerva Neurosciences, Inc", "longName": "Minerva Neurosciences, Inc.", "firstTradeDateEpochUtc": 1404221400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ceeb0642-b36f-3eda-bb3a-75cdc1b13e8a", "messageBoardId": "finmb_261133065", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.21, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 26528792, "totalCashPerShare": 3.793, "ebitda": -24492732, "totalDebt": 60000000, "quickRatio": 5.918, "currentRatio": 6.232, "returnOnAssets": -0.28905, "freeCashflow": -16768544, "operatingCashflow": -20375168, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-15"}]